Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pancreatic cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-9 of 9 for your search:
Start Over
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Combination Chemotherapy Followed by Ipilimumab and Vaccine Therapy in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13108, NCI-2013-02238, FD-R-004819-01, NA_00086350, 9478, NCT01896869
Vaccine Therapy and Cyclophosphamide with or without Nivolumab in Treating Patients with Previously Treated Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J14113, NCI-2015-00233, ADU-CL-06, CA209-248, NCT02243371
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NLG0605, NCI-2015-01697, 1409-1350, NCT02405585
INO-1400 Vaccine Alone or in Combination with INO-9012 Followed by Electroporation in Treating Patients with Breast, Lung, or Pancreatic Cancer at High Risk of Relapse after Surgery and Standard Treatment
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #22913 / Inovio TRT-00, NCI-2015-00389, 821038, UPCC 22913, NCT02327468
Vaccine Therapy and Pembrolizumab in Treating Patients with Solid Tumors That Have Failed Prior Therapy
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15002, NCI-2015-00653, 116634, 122284, 122771, 124524, NCT02432963
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Vaccine Therapy with or without Nivolumab Before and After Surgery in Treating Patients with Stage I-IIb Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1568, NCI-2016-00268, CRMS-61622, IRB00050517, NCT02451982
Personalized Peptide Vaccine in Treating Patients with Advanced Pancreatic Cancer or Colorectal Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-1029, NCI-2016-00015, NCT02600949
Start Over